E. Sindern et al., THE CLINICAL-SIGNIFICANCE OF HIGH ANTI-GM 1 ANTIBODIES IN ACUTE GUILLAIN-BARRE-SYNDROME, Aktuelle Neurologie, 22(4), 1995, pp. 136-139
Anti-GM1 IgG and IgM antibodies were measured in the serum of 20 patie
nts with acute Guillain-Barre Syndrome (GBS) and compared with anti-GM
1 antibody activity in patients with herpes tester, meningoradiculitis
Bannwarth, different chronic polyneuropathies and in healthy voluntee
rs. We found high IgG anti-GM1 antibodies (titre > 1:6400) only in 3 G
BS patients (15%). AU three patients had preceeding diarrhoea and sero
logical evidence of Campylobacter jejuni enteritis. At the maximum of
the illness they were tetraplegic or tetraparetic with no sensory defi
cits. Half a year later one had a good recovery, one was wheel-chair b
ound and one remained bedridden. Electrophysiological examination reve
aled evidence of demyelination early in the disease. Later secondary a
xonal damage was found. IgG anti-GM1 antibodies may define a subgroup
of GBS patients with severe motor neuropathy that is frequently associ
ated with preceeding C. jejuni enteritis.